2026 International Spring Forum
April 15, 2026 | 12:00 PM EST
- Home
- Clinical Resources Search
- PQI: Encorafenib (Braftovi®) + Cetuximab (Erbitux®) + mFOLFOX6 for BRAF V600E-Positive Metastatic Colorectal Cancer
Encorafenib (Braftovi®) + Cetuximab (Erbitux®) + mFOLFOX6 for BRAF V600E-Positive Metastatic Colorectal Cancer
About this PQI
The purpose of this PQI is to review clinical considerations related to the use of encorafenib combined with cetuximab and mFOLFOX6 (EC + mFOLFOX6) in patients with BRAF V600E-mutated metastatic colorectal cancer (mCRC).

How to Use a Positive Quality Intervention (PQI)
Essentially, it’s a tool to improve patient care by sharing best practices in oncology care. Consider this standardized, peer-review clinical guidance to oncology healthcare teams, enabling you and your team to consistently deliver high-quality care to your patients.
Find a PQIFind Similar Resources
All Resources
PQI
PQI
PQI
PQI
PQI: Eflapegrastim-xnst (Rolvedon) for Chemotherapy-Induced Neutropenia
Author: Syed Zia Khan, PharmD, BCSCP
Last Updated: 09/27/2025
PQI: Revumenib (Revuforj) for the Management of Acute Leukemia
Author: Tracelyn Freeman, PharmD, BCOP
Last Updated: 09/27/2025
PQI: Talectrectinib (Ibtrozi) for the Management of ROS1+ Advanced NSCLC
Author: Stefanie Houseknecht, PharmD, BCOP
Last Updated: 09/27/2025
PQI: Zanidatamab-hrii (Ziihera) for the Management of Biliary Tract Cancer
Author: Shelbie Gibbs, PharmD, BCOP
Last Updated: 09/27/2025
PQI in Action
PQI in Action
PQI in Action
PQI in Action
PQI in Action: Abiraterone acetate (Yonsa®) Patient Selection and Management
Author: Atlanticare Cancer Care Institute | Cancer Specialists of North Florida
Last Updated: 09/27/2025
PQI in Action: Enfortumab Vedotin-ejfv (Padcev®) and Pembrolizumab (Keytruda®) Management for Advanced or Metastatic Urothelial Carcinoma
Author: Huntsman Cancer Institute | University Hospitals
Last Updated: 09/27/2025
PQI in Action: Fruquintinib (Fruzaqla®)
Author: Florida Cancer Specialists & Research Institute | Atlanticare Cancer Care Institute
Last Updated: 09/27/2025
PQI in Action: Management of Tucatinib (Tukysa®) and Trastuzumab in HER2-Positive Metastatic Colorectal Cancer – 2
Author: Johns Hopkins, MD | The University of Texas MD Anderson Cancer Center, TX
Last Updated: 09/27/2025
Treatment Support Kit
Treatment Support Kit
Treatment Support Kit
Treatment Support Kit
Treatment Support Kit: Elranatamab
Last Updated: 09/27/2025
Treatment Support Kit: Mirdametinib
Last Updated: 09/27/2025
Treatment Support Kit: Abemaciclib
Last Updated: 09/27/2025
Treatment Support Kit: Temozolomide
Last Updated: 09/27/2025
PQI
PQI
PQI
PQI Podcast
PQI: Tucatinib (TUKYSA®) and trastuzumab in HER2-positive Metastatic Colorectal Cancer
Author: Matthew Arango, PharmD, BCOP
Last Updated: 09/27/2025
PQI: Trifluridine and Tipiracil (Lonsurf®) for Metastatic Colorectal Cancer
Author: Jennifer M. Hasiak O’Doherty, PharmD
Last Updated: 09/27/2025
PQI: Regorafenib (Stivarga®) in Metastatic Colorectal Cancer
Author: Neal Dave, PharmD | Natasha Khrystolubova, RPh, BPharm, BCOP
Last Updated: 09/27/2025
PQI Podcast S6 Ep 2: Molecular Testing & Targeted Treatment in Colorectal Cancer
Author: Ginger Blackmon, PharmD | Makenna Smack, PharmD, BCOP
Last Updated: 09/27/2025
PQI Podcast
PQI
PQI Podcast
PQI Podcast
S9 E5: Global Health, Cancer Survivorship, and Advancing Equity
Author: Ginger Blackmon, PharmD | Ornesha Watson, PharmD, MS
Last Updated: 09/27/2025
PQI: Eflapegrastim-xnst (Rolvedon) for Chemotherapy-Induced Neutropenia
Author: Syed Zia Khan, PharmD, BCSCP
Last Updated: 09/27/2025
S9 E4: Advancing Pharmacogenomics in Oncology
Author: Ginger Blackmon, PharmD | Sony Tuteja
Last Updated: 09/27/2025
S9 E3: Firefighter Health & Cancer Prevention
Author: Ginger Blackmon, PharmD | Tim Thompson
Last Updated: 09/27/2025